Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Monika Karin"'
Autor:
Julian Taugner, Chukwuka Eze, Lukas Käsmann, Olarn Roengvoraphoj, Kathrin Gennen, Monika Karin, Oleg Petrukhnov, Amanda Tufman, Claus Belka, Farkhad Manapov
Publikováno v:
Radiation Oncology, Vol 15, Iss 1, Pp 1-9 (2020)
Abstract Background Loco-regional and distant failure are common in inoperable stage III non small-cell lung cancer (NSCLC) after chemoradiotherapy (CRT). However, there is limited real-world data on failure pattern, patient prognosis and salvage opt
Externí odkaz:
https://doaj.org/article/a344673347554281b6d472de0edb625a
Autor:
Kathrin Gennen, Lukas Käsmann, Julian Taugner, Chukwuka Eze, Monika Karin, Olarn Roengvoraphoj, Jens Neumann, Amanda Tufman, Michael Orth, Simone Reu, Claus Belka, Farkhad Manapov
Publikováno v:
Radiation Oncology, Vol 15, Iss 1, Pp 1-12 (2020)
Abstract Background/aim mmune checkpoint inhibition (CPI) has an increasing impact in the multimodal treatment of locally advanced non-small cell lung cancer (LA-NSCLC). Increasing evidence suggests treatment outcome depending on tumor cell PD-L1 exp
Externí odkaz:
https://doaj.org/article/2bbd9933800948f78581ecc46477f86f
Autor:
Monika Karin, Julian Taugner, Lukas Käsmann, Chukwuka Eze, Olarn Roengvoraphoj, Amanda Tufman, Claus Belka, Farkhad Manapov
Publikováno v:
Cancers, Vol 12, Iss 10, p 3035 (2020)
Inoperable stage III non-small cell lung cancer (NSCLC) represents a highly heterogeneous patient cohort. Multimodal treatment approaches including radiotherapy have been the new standard of care, with promising outcomes. The planning target volume (
Externí odkaz:
https://doaj.org/article/4cd66a6570534f04a89991b62efffb32
Autor:
Julian Taugner, Julian Guggenberger, Farkhad Manapov, Thomas Duell, Amanda Tufman, Benedikt Flörsch, Monika Karin, Niels Reinmuth, Lukas Käsmann, Claus Belka, Chukwuka Eze, Minglun Li
Publikováno v:
Investigational New Drugs
SummaryBackground. The present study evaluates outcome after chemoradiotherapy (CRT) with concurrent and/or sequential Programmed Cell Death 1 (PD-1) or Ligand 1 (PD-L1) immune checkpoint inhibition (CPI) for inoperable stage III NSCLC patients depen
Autor:
Amanda Tufman, Maurice Dantes, Olarn Roengvoraphoj, Farkhad Manapov, Monika Karin, K. Gennen, Claus Belka, Chukwuka Eze, Lukas Käsmann, Julian Taugner, Oleg Petrukhnov
Publikováno v:
Anticancer Research. 39:5077-5081
Background/aim Patient performance scores are used widely in clinical practice to assess a patient's general condition. The aim of this study was to evaluate the prognostic role of Eastern Cooperative Oncology Group performance score (ECOG PS) before
Autor:
Claus Belka, Chukwuka Eze, Amanda Tufman, Benedikt Flörsch, Monika Karin, Julian Taugner, L. Kaesmann, Farkhad Manapov, Julian Guggenberger
Publikováno v:
Journal of Thoracic Oncology. 16:S741-S742
Autor:
Monika Karin, Olarn Roengvoraphoj, K. Gennen, Oleg Petrukhnov, Amanda Tufman, Farkhad Manapov, Chukwuka Eze, Julian Taugner, Lukas Käsmann, Claus Belka
Publikováno v:
Radiation oncology (London, England), vol 15, iss 1
Radiation Oncology (London, England)
Radiation Oncology, Vol 15, Iss 1, Pp 1-9 (2020)
Radiation Oncology (London, England)
Radiation Oncology, Vol 15, Iss 1, Pp 1-9 (2020)
Background Loco-regional and distant failure are common in inoperable stage III non small-cell lung cancer (NSCLC) after chemoradiotherapy (CRT). However, there is limited real-world data on failure pattern, patient prognosis and salvage options. Met
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::daf36a26f6f20cbd8bfd782a4bdd9285
https://escholarship.org/uc/item/7pf9v39p
https://escholarship.org/uc/item/7pf9v39p
Autor:
Olarn Roengvoraphoj, Chukwuka Eze, Claus Belka, Michael Hoffmann, Monika Karin, Farkhad Manapov, D. Reitz, Julian Taugner, Lukas Käsmann
Publikováno v:
Anticancer research. 40(4)
Aim We investigated blood parameters in patients with inoperable stage III non-small cell lung cancer (NSCLC) to predict individual outcomes after definitive chemoradiotherapy (CRT). Patients and methods Blood parameters of consecutive patients under
Autor:
Amanda Tufman, Monika Karin, Claus Belka, Julian Taugner, M. Orth, Lukas Käsmann, Olarn Roengvoraphoj, Chukwuka Eze, K. Gennen, Jens Neumann, Farkhad Manapov, Simone Reu
Publikováno v:
Radiation oncology (London, England), vol 15, iss 1
Radiation Oncology (London, England)
Radiation Oncology, Vol 15, Iss 1, Pp 1-12 (2020)
Radiation Oncology (London, England)
Radiation Oncology, Vol 15, Iss 1, Pp 1-12 (2020)
Background/aim mmune checkpoint inhibition (CPI) has an increasing impact in the multimodal treatment of locally advanced non-small cell lung cancer (LA-NSCLC). Increasing evidence suggests treatment outcome depending on tumor cell PD-L1 expression.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::93c86b4c31aa9a3a45a307bee18bffe9
https://escholarship.org/uc/item/2wt2p99z
https://escholarship.org/uc/item/2wt2p99z
Autor:
Chukwuka Eze, Monika Karin, K. Gennen, Maurice Dantes, Oleg Petruknov, Olarn Roengvoraphoj, Amanda Tufman, Farkhad Manapov, Julian Taugner, Claus Belka, Lukas Käsmann
Publikováno v:
Translational lung cancer research, vol 8, iss 5
BACKGROUND: Stage III non-small cell lung cancer (NSCLC) represents a heterogeneous disease regarding principal patient- and tumor characteristics. A simple score may aid in personalizing multimodal therapy. METHODS: The data of 99 consecutive patien